Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line

por Raimonda Kubiliute, Indre Januskeviciene, Ruta Urbanaviciute, Kristina Daniunaite, Monika Drobniene, Valerijus Ostapenko, Rimantas Daugelavicius, Sonata Jarmalaite
Publicado 2021

Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients

por Gedmante Radziuviene, Gedmante Radziuviene, Allan Rasmusson, Allan Rasmusson, Renaldas Augulis, Renaldas Augulis, Ruta Barbora Grineviciute, Dovile Zilenaite, Dovile Zilenaite, Aida Laurinaviciene, Aida Laurinaviciene, Valerijus Ostapenko, Arvydas Laurinavicius, Arvydas Laurinavicius
Publicado 2021

The Impact of the COVID-19 Pandemic on Cancer Patient’s Management—Lithuanian Cancer Center Experience

por Daiva Dabkeviciene, Ieva Vincerzevskiene, Vincas Urbonas, Jonas Venius, Audrius Dulskas, Birute Brasiuniene, Ernestas Janulionis, Arvydas Burneckis, Asta Zileviciene, Sigitas Tiskevicius, Rasa Vanseviciute-Petkeviciene, Jurgita Usinskiene, Ruta Briediene, Giedre Bulotiene, Eugenijus Stratilatovas, Valerijus Ostapenko, Jolita Gibaviciene, Ignas Karnas, Saule Kekstaite, Jurgita Navickiene, Albertas Ulys, Algirdas Zalimas, Algimantas Sruogis, Zygimantas Kardelis, Sigitas Zaremba, Renatas Askinis, Saulius Cicenas, Renatas Tikuisis, Ruta Ciurliene, Sonata Jarmalaite
Publicado 2021